!!Projects per year
Fingerprint
Dive into the research topics where Sameek Roychowdhury is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical validation of FGFR-Dx in plasma cell-free DNA from patients with FGFR-altered advanced pancreatic cancer
Roychowdhury, S. (PI)
07/17/26 → 06/30/27
Project: Research
-
Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-altered Cancers
Roychowdhury, S. (PI)
09/1/23 → 08/31/26
Project: Research
-
Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-altered Cancers
Roychowdhury, S. (PI)
09/22/21 → 08/31/23
Project: Research
-
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility
Roychowdhury, S. (PI)
04/9/19 → 03/31/21
Project: Research
-
Assay Validation of Targeted RNA sequencing to Detect Kinase Gene Fusions
Roychowdhury, S. (PI)
08/10/18 → 07/31/21
Project: Research
-
A phase II trial of perioperative tumor treating fields (NovoTTF-200T[P]) combined with gemcitabine and nab-paclitaxel in resectable pancreatic adenocarcinoma: Big Ten Cancer Research Consortium (BTCRC-GI21-500).
Khorasanchi, A., Noonan, A. M., Jin, N., Hays, J. L., Roychowdhury, S., Malalur, P., Rahman, S., Cloyd, J. M., Dillhoff, M., Tsai, S., Mittra, A. & Manne, A., Jan 2026, In: Journal of Clinical Oncology. 44, p. TPS797-TPS797Research output: Contribution to journal › Review article › peer-review
Open Access -
A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation
Alsouqi, A., Huang, Y., Christian, B., Reneau, J., Bhat, S. A., Brammer, J., Sawalha, Y., Baiocchi, R. A., Grever, M., Rogers, K. A., Reeser, J., Smith, A., Samorodnitsky, E., Roychowdhury, S., Maddocks, K., Woyach, J. A. & Bond, D., Mar 2026, In: European Journal of Haematology. 116, 3, p. 326-329 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Multi-omic characterization of 14q deletion in renal clear cell carcinoma identifies EDNRB as a predictor of immunotherapy response
Vella, R., Hoskins, E. L., Miller, I. D., Reeser, J. W., Wing, M. R., Sheel, A., Samorodnitsky, E., Lenz, S. A., Collier, K., Li, M., Chowdhury, S. M., Yang, Y., Parwani, A. & Roychowdhury, S., Jul 2026, In: Journal for ImmunoTherapy of Cancer. 14, 7, e014201.Research output: Contribution to journal › Article › peer-review
Open Access -
Nationwide Fully Decentralized Telemedicine Therapeutic Trial for Advanced Pancreatic Cancer: Implementation and First Enrollment
Risch, Z. A., Reeser, J. W., Wing, M. R., Jackman, C., Bushong, B., Smith, A., Dao, T., Samorodnitsky, E., Pan, X., Gupta, A. & Roychowdhury, S., Sep 2026, In: JCO Precision Oncology. 10, 9Research output: Contribution to journal › Article › peer-review
-
Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301
Abou-Alfa, G. K., Borbath, I., Roychowdhury, S., Goyal, L., Lamarca, A., Macarulla, T., Shroff, R. T., Oh, D. Y., Tamaş, C., Savastano, D. M., van Veenhuyzen, D. F., Xu, C., Freas, E., Solanas, J. & Javle, M. M., Apr 2026, In: ESMO Open. 11, 4, 106306.Research output: Contribution to journal › Article › peer-review
Open Access6 !!Link opens in a new tab Scopus citations